Please select the option that best describes you:

Do you recommend hypofractionated radiotherapy for elderly and/or poor KPS patients with diffuse IDH-mutant grade 2 glioma by extrapolation from high-grade glioma trials?   

Is there any data to suggest higher risk of malignant transformation with hypofractionation? Does concurrent Temozolomide change your approach? 



Answer from: Radiation Oncologist at Academic Institution
Sign in or Register to read more